Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer.
Alessandro ParodiMagdalena RudzińskaAndrei A DeviatkinSurinder M SoondAlexey V BaldinAndrey A ZamyatninPublished in: Pharmaceutics (2019)
Brain tumors are characterized by very high mortality and, despite the continuous research on new pharmacological interventions, little therapeutic progress has been made. One of the main obstacles to improve current treatments is represented by the impermeability of the blood vessels residing within nervous tissue as well as of the new vascular net generating from the tumor, commonly referred to as blood-brain barrier (BBB) and blood-brain tumor barrier (BBTB), respectively. In this review, we focused on established and emerging strategies to overcome the blood-brain barrier to increase drug delivery for brain cancer. To date, there are three broad strategies being investigated to cross the brain vascular wall and they are conceived to breach, bypass, and negotiate the access to the nervous tissue. In this paper, we summarized these approaches highlighting their working mechanism and their potential impact on the quality of life of the patients as well as their current status of development.
Keyphrases
- blood brain barrier
- drug delivery
- cerebral ischemia
- resting state
- papillary thyroid
- white matter
- end stage renal disease
- current status
- squamous cell
- functional connectivity
- ejection fraction
- newly diagnosed
- chronic kidney disease
- cancer therapy
- peritoneal dialysis
- prognostic factors
- cardiovascular events
- cardiovascular disease
- physical activity
- lymph node metastasis
- subarachnoid hemorrhage
- squamous cell carcinoma
- type diabetes
- brain injury
- young adults
- coronary artery disease
- high resolution
- human health
- patient reported